E
Petros Pharmaceuticals, Inc. PTPI
$0.0345 -$0.0015-4.17% OTC PK
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

03/31/2025 12/31/2024
Revenue -- -53.98%
Total Other Revenue -- --
Total Revenue -- -53.98%
Cost of Revenue -- -7.74%
Gross Profit -- -64.28%
SG&A Expenses 0.59% -37.01%
Depreciation & Amortization -- -11.27%
Other Operating Expenses -- --
Total Operating Expenses -41.02% -36.86%
Operating Income 16.53% 25.33%
Income Before Tax 87.07% -317.59%
Income Tax Expenses -- --
Earnings from Continuing Operations 87.07% -317.59%
Earnings from Discontinued Operations -- --
Extraordinary Item & Accounting Change -- --
Minority Interest in Earnings -- --
Net Income 75.63% -317.59%
EBIT 16.53% 25.33%
EBITDA 31.21% 31.83%
EPS Basic 64.87% -99.96%
Normalized Basic EPS 93.38% -176.18%
EPS Diluted 64.87% -99.96%
Normalized Diluted EPS 93.38% -176.18%
Average Basic Shares Outstanding 187.36% 2.82%
Average Diluted Shares Outstanding 187.36% 2.82%
Dividend Per Share -- --
Payout Ratio -- --